00-82-0725
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| g | ￥ ǠƔƉȝȝ | > 0 | > 0 | -- | -- | -- | -- | ￥ ǠƔƉȝȝ | - + |
| 5g | ￥ ŤľƉȝȝ | > 0 | > 0 | -- | -- | 3 | -- | ￥ ŤľƉȝȝ | - + |
| 0g | ￥ ȅǘƉȝȝ | > 0 | > 0 | 2 | 3 | 2 | ￥ ȅǘƉȝȝ | - + | |
| 25g | ￥ ľǘƉȝȝ | > 0 | > 0 | -- | 5 | 2 | ￥ ľǘƉȝȝ | - + | |
| 00g | ￥ ǠƔȹƉȝȝ | 0 | 8 | -- | -- | ￥ ǠƔȹƉȝȝ | - + | ||
| 500g | ￥ ſȅǠȅƉȝȝ | 2 | -- | -- | -- | -- | ￥ ſȅǠȅƉȝȝ | - + | |
| kg | ￥ ǠȅǠſƉȝȝ | -- | -- | -- | -- | -- | ￥ ǠȅǠſƉȝȝ | - + | |
| 大货 | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
.05
[]. Zhang XD, et, al. The effect of apatinib on pharmacokinetic profile of buspirone both in vivo and in vitro. J Pharm Pharmacol. 2020 Oct;72(0):05-.
[2]. A H Vaidya, et al. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and -PP to anxiolytic action. Methods Find Exp Clin Pharmacol. 2005 May;27():25-55.
[3]. Donald M N Sikazwe, et al. Synthesis and evaluation of ligands for D2-like receptors: the role of common pharmacophoric groups. Bioorg Med Chem. 2009 Feb 5;7():76-23.
[]. I Berlin, et al. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite -(2-pyrimidinyl)-piperazine. Br J Clin Pharmacol. 995 Mar;39(3):23-9.
[5]. J Odontiadis, et al. Simultaneous quantitation of buspirone and its major metabolite -(2-pyrimidinyl)piperazine in human plasma by high-performance liquid chromatography with coulometric detection. J Pharm Biomed Anal. 996 Jan;(3):37-5.
H302-H35-H39-H335
P26-P26-P270-P27-P280-P302+P352-P30+P30-P305+P35+P338-P330-P362+P36-P03+P233-P05-P50
05325 现货
￥ ŤſƉȝȝ -g
220 现货
￥ ľľƉȝȝ -g
390099 货期咨询
300235 货期咨询
0673 货期咨询
760 货期咨询
68392 货期咨询
3525 货期咨询
￥ ƢƔǘȝƉȝȝ -0g
00593 货期咨询
￥ ƢŤŤƢƉȝȝ -g
286632 货期咨询
￥ ƢȹǘƉȝȝ -g
沪ICP备70965号
